Wynne Stephanie C, Ashworth Mark
Rehabilitation and Therapies Department, Guy's and St Thomas' NHS Foundation Trust, London, UK
School of Life Course and Population Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
BJGP Open. 2025 Jul 23;9(2). doi: 10.3399/BJGPO.2024.0052. Print 2025.
Practices with higher 2-week-wait (2WW) referral rates demonstrate higher survival for several cancers. Yet, there is little up-to-date evidence exploring factors influencing 2WW referral rates and whether health inequalities exist, particularly after COVID-19.
To establish which patient factors (for example, age, sex, ethnic group, deprivation) and practice factors (for example, remote consultations, frequency of seeing a preferred GP) independently predict 2WW referral rates.
DESIGN & SETTING: A cross-sectional, observational study was performed using data from English general practices for 2021-2022.
Multivariable linear regression was used to identify the strongest, independent predictors of 2WW referral rates for all cancers (primary outcome) and for breast, lower-gastrointestinal, lung, and skin cancers separately (secondary outcome).
The analysis included 6307 practices. Practices with more females, patients aged ≥75 years, and patients with a greater burden of long-term conditions were associated with higher 2WW referrals for all cancers, as were practices in Northwest England, and those with higher scores for patients feeling involved in care decisions. Conversely, practices with a higher frequency of seeing a preferred GP were predictive of fewer all-cancer 2WW referrals. Practices with a higher proportion of currently smoking patients and Asian and Black ethnicity patients also predicted fewer all-cancer 2WW-referrals, and these associations were strongest for skin cancer, and for breast cancer (except for Black ethnicity). Higher socioeconomic deprivation predicted lower 2WW referrals for lung cancer only.
This study analyses factors influencing 2WW referral rates and highlights potential inequalities. This work identifies priority populations, including people who smoke, and Asian and Black ethnic group patients, who may benefit from interventions to increase primary care access. Shared decision making may be an underexplored resource for increasing all-cancer 2WW referral rates.
两周等待期(2WW)转诊率较高的医疗机构中,几种癌症患者的生存率更高。然而,目前几乎没有最新证据探讨影响2WW转诊率的因素以及是否存在健康不平等现象,尤其是在新冠疫情之后。
确定哪些患者因素(如年龄、性别、种族、贫困程度)和医疗机构因素(如远程会诊、看首选全科医生的频率)能独立预测2WW转诊率。
采用2021 - 2022年英国全科医疗数据进行横断面观察性研究。
使用多变量线性回归分别确定所有癌症(主要结局)以及乳腺癌、下消化道癌、肺癌和皮肤癌(次要结局)2WW转诊率的最强独立预测因素。
分析纳入6307家医疗机构。女性患者、75岁及以上患者以及长期疾病负担较重的患者较多的医疗机构,与所有癌症的2WW转诊率较高相关,英格兰西北部的医疗机构以及患者在护理决策中参与感得分较高的医疗机构也是如此。相反,看首选全科医生频率较高的医疗机构预测所有癌症的2WW转诊较少。目前吸烟患者、亚洲和黑人种族患者比例较高的医疗机构也预测所有癌症的2WW转诊较少,这些关联在皮肤癌和乳腺癌(黑人种族除外)中最为明显。社会经济贫困程度较高仅预测肺癌的2WW转诊率较低。
本研究分析了影响2WW转诊率的因素并突出了潜在的不平等现象。这项工作确定了优先人群,包括吸烟者以及亚洲和黑人种族患者,他们可能受益于增加初级医疗服务可及性的干预措施。共同决策可能是提高所有癌症2WW转诊率的一个未充分探索的资源。